At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 825 enrolled
Drug / intervention
Adapalene and Benzoyl Peroxide Topical Gel +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo's Adapalene/BP Gel to Galderma's Epiduo (Adapalene/BP) Gel, and Both Treatments to a Vehicle Control in the Treatment of Acne Vulgaris
In Brief
A Phase 3 clinical trial evaluating Adapalene and Benzoyl Peroxide Topical Gel, Epiduo Topical Product, and 1 other intervention for Acne Vulgaris. Completed, enrolled 825 participants across 1 site.
Detailed Summary
To compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment of Acne Vulgaris
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201820192020202120222023202420252026
Enrollment StartDec 2017
First PostedJan 2018
Primary CompletionSep 2018
Study CompletionJan 2019
TodayJul 2026
First PostedJan 8, 2018
Enrollment StartDec 13, 2017
Primary CompletionSep 30, 2018
Study CompletionJan 5, 2019
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 8.5 years ago
Interventions
Adapalene and Benzoyl Peroxide Topical Geldrug
Test product
Epiduo Topical Productdrug
RLD product
Placebodrug
Placebo gel